Company filings profile · CIK 0001723128
Amneal Pharmaceuticals, Inc. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for Amneal Pharmaceuticals, Inc. (AMRX): 23 filings in the last 90 days vs 9 in the prior 90 (filing-velocity rising ↑ · 2.56×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Nov 4, 2026. Source-linked, daily-refreshed.
Material 8-K events — Amneal Pharmaceuticals, Inc.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Nov 3, 2026 | Results of Operations (earnings); Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Aug 10, 2026 | Entry into a Material Agreement; Completion of Acquisition/Disposition; Material Direct Financial Obligation; Unregistered Sale of Securities; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Aug 3, 2026 | Entry into a Material Agreement | ↗ |
| Jul 31, 2026 | Item 5.07 | ↗ |
| Jul 30, 2026 | Results of Operations (earnings); Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
Watch Amneal Pharmaceuticals, Inc. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Insider transactions (Form 4 / 3 / 5)
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Nov 3, 2026 | 8-K | Results of Operations (earnings); Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Oct 23, 2026 | 8-K/A | Financial Statements and Exhibits | ↗ |
| Sep 21, 2026 | 4 | FORM 4 | ↗ |
| Sep 14, 2026 | 4 | FORM 4 | ↗ |
| Sep 3, 2026 | S-3ASR | S-3ASR | ↗ |
| Sep 2, 2026 | 4 | FORM 4 | ↗ |
| Aug 25, 2026 | 4 | FORM 4 | ↗ |
| Aug 14, 2026 | 4 | FORM 4 | ↗ |
| Aug 13, 2026 | 4 | FORM 4 | ↗ |
| Aug 13, 2026 | 4 | FORM 4 | ↗ |
| Aug 13, 2026 | 4 | FORM 4 | ↗ |
| Aug 13, 2026 | 144 | ↗ | |
| Aug 12, 2026 | 4 | FORM 4 | ↗ |
| Aug 12, 2026 | SCHEDULE 13D/A | ↗ | |
| Aug 12, 2026 | SCHEDULE 13D/A | ↗ | |
| Aug 12, 2026 | SCHEDULE 13D/A | ↗ | |
| Aug 12, 2026 | 4 | FORM 4 | ↗ |
| Aug 12, 2026 | 4 | FORM 4 | ↗ |
| Aug 12, 2026 | 4 | FORM 4 | ↗ |
| Aug 12, 2026 | 144 | ↗ | |
| Aug 12, 2026 | 144 | ↗ | |
| Aug 11, 2026 | 144 | ↗ | |
| Aug 10, 2026 | 8-K | Entry into a Material Agreement; Completion of Acquisition/Disposition; Material Direct Financial Obligation; Unregistered Sale of Securities; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Aug 6, 2026 | 10-Q | 10-Q | ↗ |
| Aug 3, 2026 | 8-K | Entry into a Material Agreement | ↗ |
| Jul 31, 2026 | 8-K | Item 5.07 | ↗ |
| Jul 30, 2026 | DEFA14A | DEFA14A | ↗ |
| Jul 30, 2026 | 8-K | Results of Operations (earnings); Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Jun 29, 2026 | DEFM14A | DEFM14A | ↗ |
| Jun 18, 2026 | PREM14A | PREM14A | ↗ |
| May 12, 2026 | 4 | FORM 4 | ↗ |
| May 11, 2026 | 144 | ↗ | |
| May 8, 2026 | 4 | FORM 4 | ↗ |
| May 8, 2026 | 4 | FORM 4 | ↗ |
| May 8, 2026 | 4 | FORM 4 | ↗ |
| May 8, 2026 | 4 | FORM 4 | ↗ |
| May 8, 2026 | 4 | FORM 4 | ↗ |
| May 8, 2026 | 4 | FORM 4 | ↗ |
| May 8, 2026 | 4 | FORM 4 | ↗ |
| May 8, 2026 | 4 | FORM 4 | ↗ |